Faruqi & Faruqi, LLP Urges Savara Investors to Take Action Before Deadline

Urgent Notice for Savara Investors

Faruqi & Faruqi, LLP, a prominent name in securities law, has announced an investigation aiming to assist investors who have suffered losses in Savara Inc. The firm is proactively reaching out to those who acquired Savara securities between March 7, 2024, and May 23, 2025, to inform them about their potential legal options.

Important Deadlines

As part of the ongoing investigation, investors are reminded that November 7, 2025, represents a critical deadline for those interested in taking legal action. This is the date by which interested parties must seek to become lead plaintiffs in a federal securities class action lawsuit filed against the company. According to Faruqi & Faruqi, having the largest financial stake doesn't just position someone as a lead plaintiff; it ensures that they are adequately representative of the class members.

What Went Wrong?

According to the complaints lodged, Savara Inc. and its executives are accused of violating federal securities laws. Allegations point to misleading statements made by the company regarding its Biologics License Application (BLA) for a medication known as MOLBREEVI. It was suggested that the BLA lacked comprehensive information regarding the product’s chemistry and manufacturing processes, presenting the likelihood of the FDA rejecting the application.

Investors were led to believe that the BLA would move forward in a timely manner, which did not sit well with subsequent delays. The situation escalated significantly on May 27, 2025, when the company reported receiving a refusal-to-file letter from the FDA regarding the application. This news was devastating for investors, as it resulted in a sharp decline in Savara's share price, which dropped by 31.69%, equating to a loss of $0.90 per share, leaving the stock at $1.94 by the end of that trading day.

How to Take Action

For investors seeking to understand their rights and to discuss their cases, James (Josh) Wilson, a partner at Faruqi & Faruqi, is open to direct communication. Interested investors can reach out to him at 877-247-4292 or 212-983-9330 (ext. 1310). Simultaneously, the firm encourages anyone with pertinent information regarding Savara's actions, including former employees or whistleblowers, to step forward and contribute to the investigation.

Moreover, the law firm has created a resource hub on their website specifically dedicated to information regarding the Savara class action, which can be found at www.faruqilaw.com/SVRA. This platform is intended to inform and update investors throughout the legal process.

Conclusion

Faruqi & Faruqi, LLP remains dedicated to protecting the rights of investors and advocating for justice in securities litigation. The ongoing investigation represents an essential step for affected investors to potentially reclaim their losses. As the deadline approaches, it is crucial for those who believe they have been wronged by the actions of Savara Inc. to engage legal counsel and explore their options thoroughly. The processes are tightly regulated, and acting swiftly is vital to securing a position in the upcoming legal proceedings.

To keep up with ongoing updates related to this case, investors can find Faruqi & Faruqi on various social media platforms including LinkedIn, X, and Facebook.